Case Study
Calla Lily raises $1.55M and earns national visibility with ABIG Health
How strategic communications, thought leadership, and investor positioning helped an early-stage FemTech company become a credible voice in women’s health.
Challenge Overview
Calla Lily has an innovative product and a mission to advance women’s health, but lacked the visibility, credibility, and strategic communication needed to support growth.
The company needed to position its founder, Dr. Lara Zibners, as a trusted thought leader in vaginal therapeutics, while also preparing investor-facing messaging that could accelerate funding.
Obstacles
Need for Industry Authority: Calla Lily needed to establish credibility as a leader in the FemTech space.
Limited Digital Presence: The company lacked visibility in key industry media and thought leadership platforms.
Lacked Investor Readiness: While offering groundbreaking technology, Calla Lily required a stronger narrative to attract investor attention.
Growth Barriers: Difficulty in positioning Dr. Lara Zibners as the recognized voice in vaginal therapeutics.
ABIG Health’s Solution
ABIG Health crafted a communications strategy centered around positioning Dr. Lara Zibners as a credible thought leader in women’s health, supported by a bold social media plan and investor-aligned messaging. This approach elevated brand authority, attracted funding, and laid the groundwork for long-term visibility in the FemTech space..
Our Strategic Approach
-
Positioned Dr. Lara Zibners as a Thought Leader
We developed a personal brand narrative and media positioning plan to elevate Dr. Zibners’ voice as a credible expert in women’s health. This opened doors to podcast features, industry panels, and investor interest.
-
Launched a Targeted Social Media Strategy
We crafted and executed a LinkedIn content plan to build authority and grow engagement, resulting in a 31.7% increase in followers. The strategy emphasized education, clinical credibility, and innovation.
-
Created Investor-Aligned Messaging
ABIG shaped a compelling narrative that clearly communicated Calla Lily’s value proposition to potential investors. This helped drive momentum around the $1.3M seed round and additional grant funding.
-
Strengthened Brand Recognition in FemTech
We translated Calla Lily’s innovation into clear, accessible messaging across content and digital channels. This repositioned the brand as a trusted solution in the emerging vaginal therapeutics space.

The Results
$1.55M
Seed Round Raised
Successful funding for further product development.
$250,000
Grant Secured
Additional funding to support Calla Lily’s growth trajectory.
31.7% Increase
in LinkedIn Followers
And 8,300+ new followers.
Industry Leadership
Multiple speaking engagements at key FemTech and women’s health events.
Conclusion
Through strategic communications, thought leadership positioning, and investor-ready messaging, ABIG Health helped Calla Lily build credibility, increase visibility, and accelerate growth. The partnership supported a successful seed round and grant funding while positioning Calla Lily and Dr. Lara Zibners as emerging leaders in women’s health.
“These guys are game changers. In just a few short months, they transformed and positioned me as a thought leader in women’s health.
Their expertise and dedication to our mission have been invaluable, and I couldn't be more grateful for their role in Calla Lily’s growth and my own personal brand. Simply put: ABIG has been an incredible partner.”
Dr. Lara Zibners Lohr
Founder of Calla Lily
